mTORC1 inhibition induces pain via IRS-1-dependent feedback activation of ERK

Mammalian target of rapamycin complex 1 (mTORC1) inhibitors are extensively used as immunosuppressants to prevent transplant rejection and in treatment of certain cancers. In patients, chronic treatment with rapamycin or its analogues (rapalogues) has been reported to lead to sensory hypersensitivit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Melemedjian, Ohannes K., Khoutorsky, Arkady, Sorge, Robert E., Yan, Jin, Asiedu, Marina N., Valdez, Arely, Ghosh, Sourav, Dussor, Gregory, Mogil, Jeffrey S., Sonenberg, Nahum, Price, Theodore J.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3742001/
https://ncbi.nlm.nih.gov/pubmed/23607966
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pain.2013.03.021
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares